Drug Transporters
Further Research on the Drug-Drug Interaction Between Gemfibrozil and Repaglinide Presented
- Drug Drug Interactions (DDI)
- September 27, 2017
- Michael Millhollen
The clinically-relevant drug-drug interaction (DDI) between the dyslipidemia drug gemfibrozil and the antidiabetic repaglinide is well-documented throughout the literature. In...
URI Drug Transporters Workshop Presentations
- Drug Transporters
- August 11, 2017
- Michael Millhollen
The University of Rhode Island College of Pharmacy’s 5th Annual Transporters in Drug Discovery and Development: Driving Knowledge from Laboratory...
XenoTech Adds New Drug Transporters to Portfolio
- Drug Transporters
- April 1, 2017
- Michael Millhollen
Transporters have become increasingly important in drug development due to the major role they play in absorption, distribution and excretion of...
XenoTech Scientists Publish Paper, Present Research Evaluating Ketoconazole and its Alternative Clinical CYP3A4-5 Inhibitors as Inhibitors of Drug Transporters
- Enzyme Inhibition
- April 25, 2016
- Michael Millhollen
XenoTech scientists published a paper in Drug Metabolism and Disposition evaluating Ketoconazole and its alternative clinical CYP3A4-5 inhibitors as inhibitors of drug...
Navigating the Transporter Wave of 2013
- Regulatory Guidance
- August 28, 2013
- Greg Loewen
The International Transporter Consortium (ITC) issued 7 papers in the July 2013 issue of Clinical Pharmacology & Therapeutics. These 7...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback